NAD+, NMN & NR – Which one should you take?
Interested in boosting your NAD+ levels but confused about the differences between NAD+, NMN and NR? Let me simplify it for you and show you why supplementing with pure NAD+ is the best way to unlock your body’s full potential.
NAD+ (or Nicotinamide Adenine Dinucleotide) is a molecule found in every cell in your body. It plays a crucial role in energy production, DNA repair, and regulating the aging process.
As we age, our NAD+ levels decrease1, leading to negative effects such as decreased energy production, impaired DNA repair, and an increased risk of age-related diseases such as Alzheimer’s and diabetes. Supplementing with NAD+ may counteract some of these negative effects.
You may have heard of NMN and NR, and you’re wondering what makes them different from NAD+.
When you supplement with pure NAD+, you’re giving your body the molecule it needs to function at its best. In contrast, NMN2 and NR3 are precursors to NAD+. Your body must convert them into NAD through a series of enzymatic reactions. Supplementing with NAD+ directly bypasses the need for these conversions and is therefore a superior way to boost NAD+ levels in the body.
What makes NAD+ better than its precursors, NMN and NR?
Ready to try pure NAD+ for yourself? Check out SL-NAD+, a sublingual wafer containing 50mg of pure NAD+ delivered straight to your bloodstream. Don’t let confusion hold you back from unlocking your body’s full potential – give SL-NAD+ a try today!
- M. R. McReynolds, K. Chellappa, J. A. Baur. Age-related NAD+ decline. Experimental Gerontology 134 (2020) 110888.
- K. F. Mills et al. Long-Term Administration of Nicotinamide Mononucleotide Mitigates Age-Associated Physiological Decline in Mice. Cell Metabolism 24, 795–806.
- S.E. Airhart et al. An open-label, non-randomized study of the pharmacokinetics of the nutritional supplement nicotinamide riboside (NR) and its effects on blood NAD+ levels in healthy volunteers. PLOS ONE | https://doi.org/10.1371/journal.pone.0186459 December 6, 2017.